Around 50–60% of non-small cell lung cancers and 90% of small cell lung tumors contain tumor protein p53 (TP53) mutations, thus TP53 represents one of the most common genetic events in this malignancy [12–14]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.